TRAF6 inhibits colorectal cancer metastasis through regulating selective autophagic CTNNB1/β-catenin degradation and is targeted for GSK3B/GSK3β-mediated phosphorylation and degradation
Authors:
- 4 March 2019
- journal article
- research article
- Published by Taylor & Francis in Autophagy
- Vol. 15 (9) , 1506-1522
Abstract
Aberrant CTNNB1 signaling is one of the fundamental processes in cancers, especially colorectal cancer (CRC). Here, we reported that TRAF6, an E3 ubiquitin ligase important for inflammatory signaling, inhibited epithelial-mesenchymal transition (EMT) and CRC metastasis through driving a selective autophagic CTNNB1 degradation machinery. Mechanistically, TRAF6 interacted with MAP1LC3B/LC3B through its LC3-interacting region ‘YxxL’ and catalyzed K63-linked polyubiquitination of LC3B. The K63-linked ubiquitination of LC3B promoted the formation of the LC3B-ATG7 complex and was critical to the subsequent recognition of CTNNB1 by LC3B for the selective autophagic degradation. However, TRAF6 was phosphorylated at Thr266 by GSK3B in most clinical CRC, which triggered K48-linked polyubiquitination and degradation of TRAF6 and thereby attenuated its inhibitory activity towards the autophagy-dependent CTNNB1 signaling. Clinically, decreased expression of TRAF6 was associated with elevated GSK3B protein levels and activity and reduced overall survival in CRC patients. Pharmacological inhibition of GSK3B activity stabilized the TRAF6 protein, promoted CTNNB1 degradation, and effectively suppressed EMT and CRC metastasis. Thus, targeting TRAF6 and its pathway may be meaningful for treating advanced CRC.Keywords
Funding Information
- National Natural Science Foundation of China (81772541, 81372574, 31540036, 81525020, 31570753, U1801282)
This publication has 31 references indexed in Scilit:
- Selective Reversible Inhibition of Autophagy in Hypoxic Breast Cancer Cells Promotes Pulmonary MetastasisCancer Research, 2017
- Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)Autophagy, 2016
- NUR77 exerts a protective effect against inflammatory bowel disease by negatively regulating the TRAF6/TLR–IL‐1R signalling axisThe Journal of Pathology, 2015
- TRAF6 is over-expressed in pancreatic cancer and promotes the tumorigenicity of pancreatic cancer cellsMedical Oncology, 2014
- Interactions between Autophagy Receptors and Ubiquitin-like Proteins Form the Molecular Basis for Selective AutophagyMolecular Cell, 2014
- Traf6 and A20 differentially regulate TLR4-Induced autophagy by affecting the ubiquitination of Beclin 1Autophagy, 2010
- Atg8‐family interacting motif crucial for selective autophagyFEBS Letters, 2010
- Epithelial-Mesenchymal Transitions in Development and DiseaseCell, 2009
- Protein Turnover Via Autophagy: Implications for MetabolismAnnual Review of Nutrition, 2007
- TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signalingGenes & Development, 1999